Using ChEMBL to Complement Schistosome Drug Discovery. [PDF]
Padalino G +5 more
europepmc +1 more source
Potency of anti-trematode in inhibiting cathepsin-2L and cathepsin-5L of <i>Fasciola gigantica</i> using homology, docking, and molecular dynamics. [PDF]
Vanda H +5 more
europepmc +1 more source
Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis. [PDF]
Qadeer A +10 more
europepmc +1 more source
In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. [PDF]
Oyinloye BE +12 more
europepmc +1 more source
Considering ivermectin for treatment of schistosomiasis. [PDF]
Golenser J, Birman I, Gold D.
europepmc +1 more source
Colonic schistosomiasis: A case report. [PDF]
Koulali H +4 more
europepmc +1 more source
Computer-Assisted Discovery of Salvia fruticosa Compounds With Schistosomicidal Activity. [PDF]
Shoko R, Mandivenga F.
europepmc +1 more source
Disulfiram and Its Derivatives: An Immortal Phoenix of Drug Repurposing. [PDF]
Omran Z, Abdullah O.
europepmc +1 more source
Xenobiotic-Metabolizing Enzymes in Trematodes. [PDF]
Mordvinov V, Pakharukova M.
europepmc +1 more source
CRISPR/Cas genome editing, functional genomics, and diagnostics for parasitic helminths. [PDF]
Koike A, Brindley PJ.
europepmc +1 more source

